Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort

Lupus

Volumn 8, Issue 3, 1999, Pages 197-209

  Alarcon G S ^a,b   Friedman, A W ^c   Straaton, K V ^a   Moulds, J M ^c   Lisse, J ^d   Bastian, H M ^a   McGwin Jr , G ^b   Bartolucci, A A ^b   Roseman, J M ^b   Reveille, J D ^c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

African American; Caucasian; Hispanic; Lupus; Outcome; Socioeconomic

Indexed keywords

ANTIMALARIAL AGENT; AUTOANTIBODY; CORTICOSTEROID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; EDUCATION; ETHNIC GROUP; FEMALE; HEALTH CARE UTILIZATION; HUMAN; ILLNESS BEHAVIOR; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; ONSET AGE; PAIN; PRIORITY JOURNAL; SOCIAL CLASS; SOCIAL SUPPORT; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032919341     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399678847704     Document Type: Article

References (70)

1. Rosner S, Ginzler E, Diamond HS et al. A multicenter study of outcome in systemic lupus erythematosus. II Cause of death. Arthritis Rheum 1982; 25: 612-617.
2. Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus.Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990; 33: 37-48.
3. Ginzler EM, Diamond HS, Weiner M et al. A multicenter study of outcome in systemic lupus erythematosus.I. Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25: 601-611.
4. Walsh SJ, Algert C, Gregorio DI et al. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol 1995; 22: 1663-1668.
5. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus: Long-term followup of an inception cohort. Arthritis Rheum 1995; 38: 1492-1499.
6. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38: 551-558.
7. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995; 38: 274-283.
8. McCarty DJ, Manzi S, Medsger TA et al. Incidence of systemic lupus erythematosus: Race and gender differences. Arthritis Rheum 1995; 38: 1260-1270.
9. Karlson EW, Daltroy LH, Lew RA et al. The relationship of socioeconomic status, race and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 47-56.
10. Studenski S, Allen NB, Caldwell DS et al. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 1987; 30: 1326-1332.
11. Kumar A, Malaviya AN, Singh RR et al. Survival in patients with systemic lupus erythematosus in India. Rheumatol Internatl 1992; 12: 107-109.
12. Nossent JC. Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients. Sem Arthritis Rheum 1993; 23: 16-21.
13. Massardo L, Martinéz ME, Villaroel L et al. Survival of Chilean patients with systemic lupus erythematosus. Sem Arthritis Rheum 1994; 24: 1-11.
14. Molina JF Molina J, Garcia C et al. Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin-Americans. Lupus 1997; 6: 63-67.
15. Karlson EW, Daltroy LH, Lew RA et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 267-273.
16. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. Am J Med 1991; 91: 345-353.
17. Ward MM, Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 1990; 150: 849-853.
18. Barron KS, Silverman ED, Gonzales J, Reveille JD. Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1993; 36: 348-354.
19. Goldstein R, Sengar DPS. Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1121-1127.
20. Olsen ML, Arnett FC, Reveille JD. Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitation autoantibodies in systemic lupus erythematosus. Arthritis Rheum 1994; 36: 94-104.
21. Olsen ML, Goldstein R, Arnett F et al. C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenet 1989; 30: 27-33.
22. Arnett FC, Reveille JD, Moutsopoulos HM et al. Ribosomal P autoantibodies in systemic lupus erythematosus: frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum 1996; 39: 1833-1839.
23. Hartung K, Baur MP, Coldewey R et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. J Clin Invest 1992; 90: 1346-1351.
24. Hochberg MC, Boyd RE, Thearn JM et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients, with emphasis on demographic subsets. Medicine 1985; 64: 285-295.
25. Samanta A, Feehally J, Roy S et al. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50: 490-492.
26. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
27. Reveille JD, Moulds JM, Ahn C et al. Systemic lupus erythematosus in three ethnic groups: I.The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998; 41: 1161-1172.
28. Alarcón GS, Rosenan J, Bartolucci AA et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998; 41: 1173-1180.
29. U. S. Department Labor Employment and Training Administration. Dictionary of Occupational Titles. 4th ed. Washington, DC: 1991.
30. Stevens G, Hoisington E. Occupational prestige and the 1980 U. S. labor force. Social Sci Res 1987; 16: 74-105.
31. Bureau of the Commerce-Census. Current population reports, Series P-23, No.28 and Series P-60, No. 68 and subsequent years. Housing and Household Economic Statistics Division, 1995.
32. Brigance A. Brigance diagnostic assessment of basic reading skills. Curriculum Associates, N Bellence, MA, 1984.
33. Bradley LA, Alarçón GS, Triana M et al. Health care seeking behavior in fibromyalgia: Associations with pain thresholds, symptom severity, and psychiatric morbidity. J Musculoskel Pain 1994; 2: 79-87.
34. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.
35. Gladman DD, Goldsmith CH, Urowitz MB et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: International validation. J Rheumatol 1994; 21: 1468-1471.
36. Gladman D, Gizzler E, Goldsmith C et al. The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
37. Krupp LB, LaRocca NG, Muir-Nash J et al. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.
38. Aarden LA, De Groot ER, Feltkamp TEW. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluoresence technique. Ann NY Acad Sci 1975; 254: 505-515.
39. Johnson DS, Edmonds JP, Holborow EJ. Precipitating antibody to DNA detected by two-stage electroimmuno-diffusion. Lancet II 1973; 883-885.
40. Hamilton RG, Harley JB, Bias WB. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus: correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1996; 31: 496-505.
41. Gulko PS, Reveille JD, Koopman WJ et al. Anticardiolipin antibodies in systemic lupus erythematosus: Clinical correlates, HLA associations, and impact on survival. J Rheumatol 1993; 20: 1684-1693.
42. Roisin J, Contant G, Martinoli J. Detection of lupus-like anticoagulants (LA). Use of hexagonal phosphatidylethanolamine and of an APTT reagent sensitive to LA. Thromb Haemostatsis 1991; 65: 2023.
43. Triplett DA, Barna LK, Unger GA. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemostasis 1995; 74: 1185-1190.
44. Cohen S, Mermelstein R, Kamarch T et al. Measuring the functional components of social support. In: Sarason I, Sarason BR, (eds) Social Support: Theory, Research, Applications. Boston: Martinus Nijhoff; 1985.
45. Pilowsky L, Spence ND. Illness Behavior Questionnaire (IBQ). In: Corcoran K, Fischer J, (eds) Measures for Clinical Practice: A source book. New York: The Free Press; 1996; 182-185.
46. Engle EW, Callahan LF, Pincus T et al. Learned helplessness in systemic lupus erythematosus: Analysis using the rheumatology attitudes index. Arthritis Rheum 1990; 33: 281-285.
47. Ware JE, Kosinski M, Keller SD. SF-36 Physical and mental health summary scales: A user's manual. 1994, Boston: The Health Institute, New England Medical Center,
48. Ware JE, Jr., Bayliss MS, Rogers WH et al. Differences in 4-year health outcomes for elderly and poor, chronically III patients treated in HMO and fee-for-service systems. Results from the medical outcomes study. J Am Med Assoc 1996; 276: 1039-1047.
49. Katz JN, Larson MG, Phillips CB et al. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992; 30: 917-925.
50. Reveille JD, Alarçón GS, Pratt PW et al. HLA-DRBI genes and disease severity in rheumatoid arthritis. Arthritis Rheum 1996; 39: 1802-1807.
51. McDaniel DO, Alarçón GS, Pratt PW et al. Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope). Ann Intern Med 1995; 123: 181-187.
52. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in blacks and whites: The problem of residual confounding and the resiliency of race. Epidemiol 1997; 8: 621-628.
53. Out HJ, van Vliet M, de Groot PG et al. Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 352-357.
54. Ishii Y, Nagasawa K, Mayumi T et al. Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus. Ann Rheum Dis 1990; 49: 387-390.
55. Picillo U, Migliaresi S, Marcialis MR et al. Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus relationships with clinical manifestations and disease activity in an Italian series. Scand J Rheumatol 1992; 21: 271-276.
56. Santiago MB, Viana V, Bueno C et al. Anticardiolipin antibodies and disease activity in systemic lupus erythematosus. Rev Hosp Clinicas Sao Paulo 1990; 45: 167-170.
57. Buttgereit F, Grunewald T, Schuler-Maul W et al. Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases. Clin Rheumatol 1997; 16: 562-569.
58. Reeves WH, Satoh M, Wang J et al. Antibodies to DNA, DNA-binding proteins, and histones. Rheum Dis Clin North Am 1994; 20: 1-28.
59. Weitzman RJ, Walker SE. Relation of titred peripheral pattern ANA to anti-DNA and disease activity in systemic lupus erythematosus. Ann Rheum Dis 1977; 36: 44-49.
60. Davis P, Percy JS, Russell AS. Correlation between levels of DNA antibodies and clinical disease activity in SLE. Ann Rheum Dis 1977; 39: 157-159.
61. Arnett FC, Hamilton RG, Roebber MG et al. Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus. J Rheumatol 1988; 15: 1773-1776.
62. Tikly M, Burgin S, Mohanlal P et al. Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical assocations. Clin Rheumatol 1996; 15: 143-147.
63. Zimmermann AF, de Messias IJ, Utiyama SR et al. Clinical, autoimmune and demographic profile in systemic lupus erythematosus (SLE) patients from Southern Brazil. J Invest Allergol Clin Immunol 1997; 7: 24-31.
64. Johnson AE, Gordon C, Palmer RG et al. The prevalence and incidence of systemic lupus erthyematosus in Birmingham, England: relationship to ethnicity and country of birth. Arthritis Rheum 1995; 38: 551-558.
65. Tucker LB, Menon S, Schaller JG et al. Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology and outcome. Br J Rheumatol 1995; 34: 866-872.
66. Liang MH, Partridge AJ, Daltroy LH et al. Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus. Arthritis Rheum 1991; 34: 1187-1196.
67. Esdaile JM, Sampalis JS, Lacaille D et al. The relationship of socioeconomic status to subsequent health status in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 423-427.
68. Maisiak R, Austin JS, West SG et al. The effect of person-centered counseling on the psychological status of persons with systemic lupus erythematosus of rheumatoid arthritis: A randomized, controlled trial. Arthritis Care Res 1996; 9: 60-66.
69. Liang MH, Rogers M, Larson M et al. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1984; 27: 13-19.
70. Friedman AW, Reveille JD, Straaton KV et al. Predictors of self-reported functional outcome in a large prospective SLE cohort study. Arthritis Care Review, 1999: 12. (In press).